TickerFacts.

UL Solutions Inc. (ULS): Capital Expenditures

Annual figures by period end, from SEC filings.

$197.00M
Year ended 2025-12-31
$242.00M
Trailing 12 months to 2026-06-30
+6.3%
3-year compound annual growth
$237.00M2022-12-31: $164.00M2023-12-31: $215.00M2024-12-31: $237.00M2025-12-31: $197.00M$197.00M
2022-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$197.00M-16.9%2026-02-19, From 2025-01-01
2024-12-31$237.00M+10.2%2026-02-19, From 2024-01-01
2023-12-31$215.00M+31.1%2026-02-19, From 2023-01-01
2022-12-31$164.00Mn/a2025-02-20, From 2022-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
UL Solutions Inc. (ULS)2025-12-31$197.00M-16.9%
NeoGenomics Inc (NEO)2025-12-31$27.01M-34.2%
Hypha Labs, Inc. (FUNI)2025-09-30$33.0K+19.2%

Compare ULS, NEO, FUNI side by side · Screen every company in Services-Testing Laboratories ↗